Haemophilia A
Haemophilia A is a rare genetic disorder where the blood does not clot properly due to a deficiency of clotting factor VIII, leading to excessive bleeding and bruising.
Nuwiq for Managing Bleeding in Hemophilia A Patients During Surgery
We are studying how well Nuwiq works alongside emicizumab for patients with severe hemophilia A undergoing major surgery. The goal is to see if it helps control bleeding effectively and safely.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you a male patient at least 12 years old?
- Do you have severe hemophilia A (FVIII activity less than 1%)?
- Have you had at least 150 exposure days to any FVIII product?
- Do you have severe liver disease or severe kidney disease?
- Have you had a FVIII inhibitor in the past?
What similar medicines might you know?
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Vihuma
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
University Hospital Centre Zagreb
Hematology Department
Zagreb, Croatia
HUS-Yhtymae
Coagulation disorders Unit, Department of Hematology
Helsinki, Finland
Centre Hospitalier Regional Universitaire De Tours
Service : Hématologie - Hémostase
La Riche, France
Sponsor: Octapharma AG
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.